BioMerieux Inks $450M Deal For Molecular Biology Co.
French in-vitro diagnostics maker bioMerieux has entered into an agreement to acquire Utah-based molecular biology company BioFire Diagnostics Inc. in a transaction worth $450 million, the companies jointly announced Tuesday....To view the full article, register now.
Already a subscriber? Click here to view full article